Puma Biotechnology (PBYI) Selling, General & Administrative (2010 - 2026)

Puma Biotechnology (PBYI) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.13 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 110.21 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 593.21 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2,715.95
7 Royalty Pharma 33.72 Bn 35.84 Bn - 161.89 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 347.92 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 247.47 Mn
10 Puma Biotechnology 451.24 Mn 357.33 Mn 44.03 Mn 17.55 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 17.55 Mn
Mar 31, 2026 18.42 Mn
Dec 31, 2025 18.38 Mn
Sep 30, 2025 16.82 Mn
Jun 30, 2025 18.05 Mn
Mar 31, 2025 17.60 Mn
Dec 31, 2024 16.62 Mn
Sep 30, 2024 16.82 Mn
Jun 30, 2024 24.97 Mn
Mar 31, 2024 21.75 Mn
Dec 31, 2023 20.18 Mn
Sep 30, 2023 22.80 Mn
Jun 30, 2023 24.46 Mn
Mar 31, 2023 22.49 Mn
Dec 31, 2022 25.04 Mn
Sep 30, 2022 23.96 Mn
Jun 30, 2022 20.58 Mn
Mar 31, 2022 20.40 Mn
Dec 31, 2021 22.46 Mn
Sep 30, 2021 26.08 Mn